AK135 for chemotherapy nerve pain and numbness
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study is testing an experimental drug (AK135) to see if it can reduce nerve pain and numbness caused by chemotherapy in people with cancer. It might help if you have ongoing nerve symptoms after finishing certain chemo treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer and developed nerve problems (pain, numbness, tingling) from chemotherapy.
- Your nerve symptoms are at least moderate (grade 2 or higher) and started after chemotherapy.
- You stopped the chemotherapy that caused the nerve problems at least 1 month ago.
- You do not have other conditions that cause nerve issues (like diabetes or autoimmune disease).
- You have not had any treatment for nerve pain in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests if adding electroacupuncture, a gentle type of acupuncture using mild electric pulses, can help relieve nerve pain, tingling, or numbness caused by chemotherapy in people with cancer.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
This study tests if electroacupuncture (a type of acupuncture with mild electric pulses) combined with exercise can help reduce numbness, tingling, or pain caused by certain chemotherapy drugs. If you have nerve symptoms from taxane or platinum chemo and can walk on your own, this may be a good fit.
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
This trial tests a new drug called JMKX000189 to see if it can safely reduce nerve pain and tingling caused by cancer chemotherapy. If you've completed cancer treatment and are struggling with these symptoms, this study may help.
Hear when a new Chemotherapy-induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.